Earningsreport

Q3/2024 9/30/2024 EPS -0.320 ZacksConsensus -0.350 ActVsEst 0.030 - Beat

Altimmune, Inc.  (ALT) 
NASDAQ:AMEX Investor Relations: altimmune.com/investors